[Antifungal drugs: the new frontier].
Baquero
F
F
D000077612:Anidulafungin; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy; D000077336:Caspofungin; D004352:Drug Resistance, Microbial; D054714:Echinocandins; D005260:Female; D005658:Fungi / Q000187:drug effects; D006801:Humans; D055666:Lipopeptides; D008297:Male; D009181:Mycoses / Q000188:drug therapy*; D010455:Peptides; D010456:Peptides, Cyclic / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology; D012106:Research; D014230:Triazoles / Q000494:pharmacology; D014344:Trypanocidal Agents / Q000494:pharmacology; D065819:Voriconazole
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D010455:Peptides; D010456:Peptides, Cyclic; D011743:Pyrimidines; D014230:Triazoles; D014344:Trypanocidal Agents; C101425:posaconazole; D000077612:Anidulafungin; D000077336:Caspofungin; D065819:Voriconazole